PSP Ocular Motor Examination

PSP Ocular Motor Examination

Introduction

The ocular motor examination is a critical component in the diagnosis of Progressive Supranuclear Palsy (PSP), as eye movement abnormalities are among the earliest and most characteristic features of the disease. Vertical supranuclear gaze palsy, particularly affecting downgaze, is considered the hallmark clinical sign that distinguishes PSP from other Parkinsonian disorders[@steele1964]. The Movement Disorder Society (MDS) has established diagnostic criteria that incorporate specific ocular motor findings as essential or supportive features for PSP diagnosis[@hoglinger2017].

This page provides a comprehensive review of the ocular motor abnormalities observed in PSP, including the neuroanatomical basis, examination techniques, quantitative testing protocols, and the utility of these findings in differentiating PSP from related disorders such as Parkinson's disease (PD) and Corticobasal Syndrome (CBS).

Neuroanatomical Basis

Neural Pathways for Vertical Eye Movements

Vertical saccades are generated by a complex network of subcortical structures. The key components include:

PSP Ocular Motor Examination

Introduction

The ocular motor examination is a critical component in the diagnosis of Progressive Supranuclear Palsy (PSP), as eye movement abnormalities are among the earliest and most characteristic features of the disease. Vertical supranuclear gaze palsy, particularly affecting downgaze, is considered the hallmark clinical sign that distinguishes PSP from other Parkinsonian disorders[@steele1964]. The Movement Disorder Society (MDS) has established diagnostic criteria that incorporate specific ocular motor findings as essential or supportive features for PSP diagnosis[@hoglinger2017].

This page provides a comprehensive review of the ocular motor abnormalities observed in PSP, including the neuroanatomical basis, examination techniques, quantitative testing protocols, and the utility of these findings in differentiating PSP from related disorders such as Parkinson's disease (PD) and Corticobasal Syndrome (CBS).

Neuroanatomical Basis

Neural Pathways for Vertical Eye Movements

Vertical saccades are generated by a complex network of subcortical structures. The key components include:

• Superior colliculus: Midbrain structure critical for initiating saccades, with separate maps for vertical and horizontal movements
• Reticular formation: Contains burst neurons that trigger saccades and pause neurons that inhibit them
• Posterior commisure: Acts as a conduit for vertical saccade signals
• Rostral interstitial nucleus of MLF (riMLF): Key for vertical saccade generation, particularly for downward movements
• Interstitial nucleus of Cajal: Involved in vertical gaze holding and torsional movements

Why Vertical Saccades Are Affected First

The selective vulnerability of vertical saccades in PSP relates to the topographical distribution of tau pathology. The neurofibrillary tangles in PSP show a predilection for:

• Brainstem nuclei controlling vertical gaze (riMLF, interstitial nucleus of Cajal)
• Pretectal area
• Superior colliculus

4R-Tauopathy and Vertical Gaze Vulnerability

The selective targeting of vertical saccade pathways in PSP reflects the unique pattern of 4-repeat (4R) tau pathology:

Molecular Mechanisms

Anatomical Predilection

The midbrain structures controlling vertical gaze have several characteristics that make them vulnerable to 4R tau:

| Structure | Function | Vulnerability Factor |
|------------|----------|---------------------|
| riMLF | Vertical saccade generation | High metabolic demand, long axons |
| Interstitial nucleus of Cajal | Vertical gaze holding | Continuous neural activity |
| Superior colliculus | Saccade initiation | Dense synaptic connections |
| Pretectal area | Pupillary control, gaze shifts | Complex integration requirements |

Progression Pattern

The hierarchical vulnerability in PSP follows a predictable pattern:

This progression reflects the rostral-to-caudal spread of tau pathology in the brainstem, with the most rostral structures (controlling vertical gaze) affected first.

Key Ocular Motor Findings in PSP

1. Vertical Supranuclear Gaze Palsy

Description: The most characteristic finding in PSP, presenting as impaired vertical saccades with relatively preserved vertical eye movements on reflexive testing (e.g., oculocephalic maneuver).

Pathophysiology: The impairment represents a supranuclear (above the oculomotor nuclei) lesion. Patients can generate vertical eye movements when prompted by head impulses or caloric testing, indicating intact brainstem ocular motor nuclei and nerves.

Pattern:

• Downgaze typically affected first — patients have difficulty looking downward
• Upgaze affected later — progression to involve upward gaze
• Horizontal saccades relatively preserved early — become impaired in later stages

2. Slowing of Vertical Saccades

Quantitative finding: Reduced peak velocity of vertical saccades, even when the saccade can be completed.

Measurement:

• Normal vertical saccade velocity: >300-400°/sec
• PSP vertical saccade velocity: Often <200°/sec
• Horizontal saccades typically remain >300°/sec in early PSP

Diagnostic utility: Slowing of vertical saccades can be detected before complete gaze palsy develops, making it valuable for early diagnosis. It is included in the MDS-PSP diagnostic criteria as a supportive finding.

3. Square Wave Jerks

Description: Involuntary, repetitive, horizontal saccadic movements that interrupt fixation. Each jerk consists of a saccade away from the target followed by a quick return.

Characteristics:

• Amplitude: Typically 1-5° (small)
• Frequency: 1-2 Hz
• Occur during attempted fixation
• More prominent in primary position

Differential diagnosis:

• PSP: Prominent square wave jerks, especially as disease progresses
• PD: Less prominent, usually in later stages
• Huntington's disease: More prominent and higher amplitude
• Normal aging: Occasional, low frequency

Other Saccadic Intrusions in PSP

While square wave jerks are the most common saccadic intrusion in PSP, several other patterns may be observed:

Glissadic Saccades

Glissades are small saccadic movements occurring at the end of primary saccades:

• Characteristics: Small amplitude (1-3°), typically in the direction of the primary saccade
• Prevalence: Present in 25-35% of PSP patients
• Pathophysiology: Impaired cerebellar-mediated saccade termination
• Clinical significance: More prominent than in PD, indicates cerebellar involvement

Antisaccade Deficits

The antisaccade task — where patients must look away from an appearing target — is particularly sensitive to PSP:

• Error rate: PSP patients make errors 40-80% of the time (normal <15%)
• Pathophysiology: Frontal lobe dysfunction affecting suppressive signals
• Clinical significance: More severe deficits than in PD, reflects frontal/executive involvement

Saccadic Latency Prolongation

PSP patients demonstrate prolonged latency for:

• Voluntary saccades: 300-500ms (normal 150-250ms)
• Reflexive saccades: Relatively preserved
• Clinical significance: Indicates cortical involvement vs. brainstem-only pathology

4. Eyelid Opening Apraxia (Blepharospasm)

Description: Inability to voluntarily open the eyes despite intact orbicularis oculi muscle function. Patients may use compensatory behaviors such as head tilt or eyebrow raising to open their eyes.

Clinical features:

• Patients report "heavy eyelids" or inability to open eyes on command
• May improve with sensory tricks (touching forehead or eyebrows)
• Often accompanied by reduced blink rate
• Can be present even when eyes are open

Differential from blepharospasm:

• Blepharospasm: Involuntary orbicularis oculi contraction (closing)
• Eyelid opening apraxia: Inability to initiate levator contraction (opening)
• Can coexist in PSP

5. Reduced Blink Rate

Description: Decreased spontaneous blink frequency, typically <10-15 blinks per minute (normal: 15-20).

Clinical features:

• Patients may report dry eyes, irritation
• Contributes to corneal exposure risk
• Often accompanies facial masking (hypomimia)

6. Convergence Insufficiency

Description: Inability to maintain convergence, leading to diplopia at near.

Clinical features:

• Difficulty reading or doing close work
• May close one eye to compensate
• Can be asymmetric

Additional Vergence Abnormalities in PSP

Beyond convergence insufficiency, PSP patients may exhibit:

Divergence Paresis

• Pattern: Limited ability to diverge eyes for distance viewing
• Clinical features: Intermittent diplopia at distance, may be mistaken for ocular motor palsy
• Pathophysiology: Midbrain pretectal area involvement

Accommodative Dysfunction

• Reduced accommodation: Difficulty focusing on near targets
• Often coexists with convergence insufficiency
• Contributes to: Reading difficulty, eye strain

Vergence Averages

| Vergence Type | PSP Finding | Clinical Impact |
|---------------|-------------|-----------------|
| Convergence | Reduced (50-70%) | Diplopia at near |
| Divergence | Variable (20-40%) | Diplopia at distance |
| Accommodative | Reduced (30-50%) | Difficulty reading |

Quantitative Testing

Research settings may assess:

• Vergence facility: Ability to change focus between near and far
• Vergence peak velocity: Speed of vergence movements
• Vergence accuracy: Endpoint accuracy

Examination Protocol

Bedside Examination

A structured bedside ocular motor examination for suspected PSP should include:

1. Fixation Assessment

• Observe patient at rest in primary gaze
• Note: square wave jerks, blink rate, eyelid position
• Duration: 30-60 seconds

2. Pursuit Testing

• Test horizontal and vertical smooth pursuit
• Use smooth, predictable targets
• Note: catch-up saccades, impaired pursuit gain

3. Saccade Assessment (Key Test)

• Horizontal saccades: Ask patient to look left-right between two targets
• Vertical saccades: Ask patient to look up-down between targets
• Test both spontaneous (self-paced) and reflexive saccades
• Critical: Compare vertical vs. horizontal saccade velocity and accuracy

4. Gaze Holding

• Test ability to hold eccentric gaze
• Note: gaze-evoked nystagmus (suggests cerebellar involvement)

5. Head Impulse Test

• Rapidly turn patient's head while they fixate on a target
• Intact vestibulo-ocular reflex allows maintained fixation
• Abnormal (corrective saccades) suggests peripheral vestibular issue

6. Oculocephalic Reflexes (Doll's Eyes)

• Only performed when patient is unable to cooperate with voluntary testing
• Test vertical and horizontal eye movements
• Preserved in supranuclear gaze palsy (brainstem intact)

7. Convergence Testing

• Test near target focus
• Note: ability to converge, nystagmus

Quantitative Oculography Protocol

For research or detailed clinical assessment, quantitative measurements provide objective data:

Equipment

• Infrared/video oculography (VOG)
• Electrooculography (EOG)
• Search coil technique (gold standard)

Standard Test Battery

• Measure: latency, velocity, accuracy

• Measure: velocity, timing

• Measure: error rate (reflects frontal lobe function)

• Measure: gain, catch-up saccades

Normal Values (Adults)

MDS-PSP Diagnostic Criteria

The 2017 MDS diagnostic criteria for PSP incorporate ocular motor findings as essential and supportive features[@hoglinger2017]:

Core Clinical Features

| Feature | PSP-RS | PSP-P |
|---------|--------|-------|
| Ocular motor dysfunction | Required | Supportive |
| Vertical supranuclear gaze palsy | Essential | — |
| Slow vertical saccades | Supportive | Supportive |
| Initiation failure | — | — |

Essential Feature for Probable PSP-RS

• Age >40 years
• Progressive disease
• Vertical supranuclear gaze palsy OR
• Slow vertical saccades AND prominent postural instability with falls within 3 years

Supportive Ocular Motor Features

• Squared wave jerks during fixation
• Eyelid opening apraxia
• Reduced blink rate
• Impaired convergence

Diagnostic Levels

Clinically definite PSP:

• Pathological confirmation OR
• Classic PSP-RS with 5+ years symptom duration

• Required: Progressive disease, age >40, at least 2 core features OR
• 1 core feature + at least 2 supportives

• Required: Progressive disease, at least 1 core feature or 2 supportives

Differential Diagnosis

PSP vs. Parkinson's Disease

| Feature | PSP | PD |
|---------|-----|-----|
| Vertical gaze palsy | Present early (70-90%) | Absent (unless advanced) |
| Vertical saccade slowing | Present early | Normal until late |
| Square wave jerks | Prominent | Mild/late |
| Eyelid opening apraxia | Common (30-50%) | Rare |
| Blink rate | Markedly reduced | Mildly reduced |
| Gaze palsy pattern | Downgaze first | None |

Key differentiators: Vertical supranuclear gaze palsy in PSP vs. normal vertical eye movements in PD is the single most important distinction. PSP patients also show saccade slowing in the vertical axis early, while PD patients maintain normal vertical saccade velocity until very late stages.

PSP vs. Corticobasal Syndrome (CBS)

| Feature | PSP-CBS | CBS |
|---------|---------|-----|
| Vertical gaze palsy | Variable (50-70%) | Uncommon |
| Square wave jerks | Present | May be present |
| Apraxia of eyelid opening | May be present | May be present |
| Ocular motor apraxia | Common | Common |

Overlap: PSP-CBS shows significant clinical overlap, as both can have ocular motor abnormalities. However:

• PSP more consistently shows vertical supranuclear gaze palsy
• CBS often has asymmetric apraxia of eyelid opening
• Quantitative saccade testing may help differentiate

PSP vs. Multiple System Atrophy (MSA)

| Feature | PSP | MSA |
|---------|-----|-----|
| Vertical supranuclear gaze palsy | Common | Rare |
| Square wave jerks | Present | May be present |
| Ocular motor findings | Vertical > horizontal | Horizontal > vertical |

Early-Stage Diagnostic Challenges

In early disease (<3 years), the diagnosis can be challenging. Red flags suggesting PSP over PD:

• Early vertical saccade slowing (even without complete gaze palsy)
• Early falls or postural instability
• Axial rigidity (neck/trunk) predominant over limb
• Dysarthria prominent early
• Reduced blink rate marked

Clinical Utility and Limitations

Advantages of Ocular Motor Examination

Limitations

Treatment Considerations

Symptomatic Management

While no disease-modifying treatments exist for PSP, some ocular motor symptoms can be managed:

• Eyelid opening apraxia: Botulinum toxin injections to orbicularis oculi may provide partial relief
• Blepharospasm: Botulinum toxin injections
• Dry eye: Artificial tears, lubricating ointments
• Convergence insufficiency: Prism glasses

Medication Effects

Dopaminergic medications (levodopa, dopamine agonists) provide minimal benefit for ocular motor symptoms in PSP, distinguishing it from PD where these medications often improve eye movements.

Summary

Ocular motor examination is a cornerstone of PSP diagnosis and monitoring. Key findings include:

These findings are incorporated into the MDS-PSP diagnostic criteria and help differentiate PSP from PD and other Parkinsonian syndromes. The examination can be performed at bedside with minimal equipment, though quantitative testing provides additional sensitivity for early diagnosis and research purposes.

References